vildagliptin
Showing 1 - 25 of 121
Type 2 Diabetes Trial in Karachi (Empagliflozin, Vildagliptin)
Completed
- Type 2 Diabetes
- Empagliflozin
- Vildagliptin
-
Karachi, Sindh, PakistanDepartment of Diabetes and Endocrinology at Sindh Government Hos
Apr 28, 2022
Disorder Related to Renal Transplantation, Diabetes Trial in Besançon (Vildagliptin, Placebo)
Recruiting
- Disorder Related to Renal Transplantation
- Diabetes
- Vildagliptin
- Placebo
-
Besançon, FranceCHU de Besançon
Aug 1, 2022
Cognitive Protective Effect of Newer Antidiabetic Drugs
Recruiting
- Type 2 Diabetes
- Dapagliflozin
- +6 more
-
Alexandria, EgyptAlexandria University
Jul 24, 2022
Diabetes, Type 2 Trial in Shinjuku-Ku (Imeglimin, Metformin, Vildagliptin)
Recruiting
- Diabetes Mellitus, Type 2
- Imeglimin
- +2 more
-
Shinjuku-Ku, Tokyo, JapanCenter Hospital of the National Center for Global Health and Med
Sep 26, 2022
Metformin and DPP4 Inhibitors on Cognition and Cardiovascular
Recruiting
- Type 2 Diabetes Mellitus
- Vildagliptin
-
Cairo, Al Kasr Al Aini, EgyptNational Institute of diabetes and endocrinology
Jun 19, 2022
Renal Impairment, Diabetes Trial in Moscow (Vildagliptin)
Completed
- Renal Impairment
- Diabetes
- Vildagliptin
-
Moscow, Russian FederationNovartis Investigator Site
Dec 11, 2020
Diabetes, Type 2 Trial in Baltimore (Vildagliptin)
Terminated
- Diabetes Mellitus, Type 2
- Vildagliptin
-
Baltimore, MarylandNovartis Investigator Site
Dec 11, 2020
Diabetes, Type 2 Trial in East Hanover, Nurnberg (vildagliptin, glimepiride, Metformin)
Completed
- Diabetes Mellitus, Type 2
- vildagliptin
- +4 more
-
East Hanover, New Jersey
- +1 more
Dec 11, 2020
Diabetes, Type 2 Trial in East Hanover, Multiple Locations (Vildagliptin, Metformin, Vildagliptin + Metformin)
Completed
- Diabetes Mellitus, Type 2
- Vildagliptin
- +2 more
-
East Hanover, New Jersey
- +1 more
Dec 11, 2020
Diabetes, Type 2 Trial in Nurnberg, Basel (vildagliptin, Gliclazide, Metformin)
Completed
- Diabetes Mellitus, Type 2
- vildagliptin
- +2 more
-
Nurnberg, Germany
- +1 more
Dec 11, 2020
Diabetes, Type 2 Trial in Basel (vildagliptin, )
Completed
- Diabetes Mellitus, Type 2
- vildagliptin
- placebo
-
Basel, SwitzerlandNovartis Pharmaceuticals
Dec 11, 2020
Diabetes, Type 2 Trial in East Hanover (Vildagliptin, pioglitazone, Placebo)
Completed
- Diabetes Mellitus, Type 2
- Vildagliptin
- +2 more
-
East Hanover, New JerseyNovartis Pharmaceuticals
Dec 11, 2020
Diabetes, Type 2 Trial in East Hanover, Multiple Locations (Vildagliptin, metformin)
Completed
- Diabetes Mellitus, Type 2
- Vildagliptin
- metformin
-
East Hanover, New Jersey
- +1 more
Dec 11, 2020
Diabetes, Type 1 Trial in Milan (rapamycin, Vildagliptin, Placebo 1)
Completed
- Diabetes Mellitus, Type 1
- rapamycin
- +3 more
-
Milan, ItalyIRCCS San Raffaele Scientific Institute
Nov 2, 2020
SDF-1 is an Important Cytokine for Neovascularization. Cleavage of SDF-1 is Reduced by DPPIV Inhibitors Trial in Frankfurt
Withdrawn
- SDF-1 is an Important Cytokine for Neovascularization. Cleavage of SDF-1 is Reduced by DPPIV Inhibitors
- Vildagliptin
-
Frankfurt, GermanyDepartment of Cardiology
Aug 31, 2020
Metabolic Syndrome, Diabete Type 2, Kidney Insufficiency Trial in Cairo (Vildagliptin, Captopril Tablets, MetFORMIN 500 Mg Oral
Unknown status
- Metabolic Syndrome
- +2 more
- Vildagliptin
- +2 more
-
Cairo, EgyptNational Diabetes & Endocrinology Institute
Jul 21, 2020
Diabetes, Type 2 Trial in Worldwide (Vildagliptin, Placebo)
Completed
- Diabetes Mellitus, Type 2
- Vildagliptin
- Placebo
-
Buenos Aires, Argentina
- +11 more
Dec 11, 2020
Diabetes, Type 2 Trial in Kuching (Vildagliptin)
Completed
- Diabetes Mellitus, Type 2
- Vildagliptin
-
Kuching, MalaysiaSarawak General Hospital
Dec 16, 2020
Type 2 Diabetes Trial in Japan (Vildagliptin)
Completed
- Type 2 Diabetes
- Vildagliptin
-
Hunabashi, Chiba, Japan
- +23 more
Dec 11, 2020
Diabetes, Type 2 Trial in Basel (Vildagliptin)
Completed
- Diabetes Mellitus, Type 2
- Vildagliptin
-
Basel, SwitzerlandNovartis
Feb 8, 2020
CHF, Type II Diabetes Trial in Worldwide (vildagliptin, of vildagliptin)
Completed
- Congestive Heart Failure
- Type II Diabetes Mellitus
- vildagliptin
- placebo of vildagliptin
-
Benesov, Czech Republic, Czechia
- +93 more
Dec 11, 2020
Diabetes, Type 2, Renal Insufficiency Trial in Worldwide (vildagliptin, Placebo)
Completed
- Diabetes Mellitus, Type 2
- Renal Insufficiency
- vildagliptin
- Placebo
-
Buenos Aires, Argentina
- +89 more
Dec 11, 2020
Diabetes, Type 2, Renal Insufficiency Trial in United States (vildagliptin, sitagliptin)
Completed
- Diabetes Mellitus, Type 2
- Renal Insufficiency
- vildagliptin
- sitagliptin
-
Mobile, Alabama
- +86 more
Dec 11, 2020